BioCentury
ARTICLE | Clinical News

Gene for thymidine kinase to render T cells sensitive to ganciclovir: Received RAC approval for a gene therapy trial in which cells transformed ex vivo to conta

June 12, 1995 7:00 AM UTC

Genetic Therapy Inc. (GTII), Gaithersburg, Md. Product: Gene for thymidine kinase to render T cells sensitive to ganciclovir Indication: Multiple myeloma: prevent graft-versus-host disease after allog...